FDA
approval
· 2022-07-15
FDA Approved: LEVETIRACETAM — Original Application (Novadoz Pharmaceuticals LLC)
Summary
FDA approves Novadoz's original ANDA for Levetiracetam, establishing a generic anti-seizure medication. Indications include epilepsy-related seizures such as pa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LEVETIRACETAM (LEVETIRACETAM)